What is the average price target for Aravive Inc (ARAV) stock?
6 analysts have analysed ARAV and the average price target is 0.26 USD. This implies a price increase of 535.91% is expected in the next year compared to the current price of 0.0401.
Aravive Inc (ARAV) Forecast, Price Target & Analyst Ratings
NASDAQ:ARAV • US03890D1081
Current stock price
0.0401 USD
-0.01 (-13.39%)
At close:
0.042 USD
+0 (+4.74%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Aravive Inc (ARAV).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 13, 2024
- Period
- Q4 / 2023
- EPS Estimate
- -$0.08
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.26
Upside
+ 535.91%
From current price of $0.04 to mean target of $0.26, Based on 6 analyst forecasts
Low
$0.25
Median
$0.26
High
$0.26
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for ARAV. The average price target is 0.26 USD. This implies a price increase of 535.91% is expected in the next year compared to the current price of 0.0401.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ARAV was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ARAV.
In the previous month the buy percentage consensus was at a similar level.
ARAV was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-08-03 | EF Hutton | Downgrade | Buy -> Hold |
| 2023-08-03 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-08-03 | BTIG | Downgrade | Buy -> Neutral |
| 2023-08-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-07-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-05 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-25 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-11 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-16 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-14 | EF Hutton | Maintains | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-14 | Piper Sandler | Maintains | Overweight |
| 2022-10-25 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-03 | Roth Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 13, 2024
- Period
- Q4 / 2023
- EPS Estimate
- -$0.08
- Revenue Estimate
- Revenue Q2Q
- -100.00%
- EPS Q2Q
- 82.26%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
-100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-23.08%
Next Earnings Summary
ARAV is expected to report earnings on 3/13/2024. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 0 USD.
The next earnings revenue estimate has been revised downward by 100% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.69M 19.79% | 7.44M 30.76% | 9.14M 22.85% | 5.61M -38.62% | -100.00% | 2.448M | 2.703M 10.42% | 3.009M 11.32% | 6.528M 116.95% | 7.242M 10.94% | ||
| EBITDA YoY % growth | -23.17M -8.93% | -39.68M -71.26% | -69.95M -76.29% | -84.15M -20.30% | -56.508M 32.85% | -68.544M -21.30% | -79.458M -15.92% | -100.062M -25.93% | -122.808M -22.73% | N/A | N/A | |
| EBIT YoY % growth | -25M -14.84% | -40.65M -62.60% | -70.84M -74.27% | -45.9M 35.21% | -7.14M 84.44% | 100.00% | -41.871M | -51.663M -23.39% | -62.577M -21.13% | -1.326M 97.88% | -306K 76.92% | |
| Operating Margin | -439.37% | -546.37% | -775.05% | -818.18% | N/A | N/A | -1,710.42% | -1,911.32% | -2,079.66% | -20.31% | -4.23% | |
| EPS YoY % growth | -1.95 -23.42% | -1.94 0.51% | -2.20 -13.40% | -0.20 90.73% | -0.09 55.00% | 0.00 100.00% | -0.81 | -0.78 3.80% | -0.94 -21.05% | 1.09 215.76% | 1.56 43.66% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 82.26% | -0.05 92.27% | -0.03 74.50% | -0.01 -103.64% | 0.00 100.00% | -0.07 -40.00% | -0.06 -100.00% | 0.00 100.00% | 0.11 | -0.01 85.71% | 0.15 350.00% | 0.32 |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | N/A | 1.599M | 7.998M | 20.902M | 57.543M | 80.743M 4,949.59% | 102.16M 1,177.32% | |
| EBITDA Q2Q % growth | -23.358M -23.13% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.12M 69.18% | -1.632M 90.89% | -1.53M 87.85% | -1.632M 81.68% | -1.428M 76.67% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.99%
EPS Next 5 Year
10.50%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-21.62%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
2.34%
EBIT Next 5 Year
-6.26%
Aravive Inc / ARAV Forecast FAQ
Can you provide the upcoming earnings date for Aravive Inc?
Aravive Inc (ARAV) will report earnings on 2024-03-13, after the market close.
What are the consensus estimates for ARAV stock next earnings?
The consensus EPS estimate for the next earnings of Aravive Inc (ARAV) is -0.08 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for Aravive Inc (ARAV) stock?
The consensus rating for Aravive Inc (ARAV) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.